Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-18

Clinical Trial Update: A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effectiveness of semaglutide for adolescents with overweight or obesity has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2023-04-18